Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Multinational Observational Longitudinal Study to Describe the Patient Characteristics, Health Care Interventions, and Health Outcomes of Patients With Major Bleedings in the Presence of Factor Xa Inhibitor Treatment

NCT06147830 is registered in ClinicalTrials.gov with AstraZeneca as lead sponsor.

NCT NCT06147830
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06147830 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Multinational Observational Longitudinal Study to Describe the Patient Characteristics, Health Care Interventions, and Health Outcomes of Patients With Major Bleedings in the Presence of Factor Xa Inhibitor Treatment
Lead sponsor
AstraZeneca
Phase
Observational
Overall status
Completed
Start date
December 4, 2023
Completion date
November 30, 2024
Enrollment
2,202 (actual)
Sites
75

Conditions

As the registry lists them; a condition with its own page is linked.

major bleeding